Elevated biliary amylase sampled from common bile duct associated with biliary tract cancer
Recruiting
- Conditions
- CA Gallbladder and Cholangiocarcinoma patients, Non malignancy patients (e.g. CBD stone)CA gallbladder, Cholangiocarcinoma, Amylase, Biliary amylase, ERCP
- Registration Number
- TCTR20240427013
- Lead Sponsor
- Thammasat University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
1. A minimum age of 20 years old
2. Undergoing Endoscopic retrograde cholangiopancreatography (ERCP) at Thammasat University hospital
Exclusion Criteria
1. Pregnant patients
2. Unstable vital signs
3. Contraindicated for Endoscopic retrograde cholangiopancreatography (ERCP)
4. Allergy to contrast media used in Endoscopic retrograde cholangiopancreatography (ERCP)
5. Previous ERCP with sphincterotomy
6. CA head of pancreas, Ampullary cancer, and CA 2nd part of duodenum
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The correlation between biliary amylase which represent pancreatobiliary reflux and incidence of biliary tract cancer (gallbladder cancer and bile duct cancer) At intervention Laboratory value of Biliary amylase
- Secondary Outcome Measures
Name Time Method Correlation of biliary tract cancer and choledocholithiasis At intervention Presentation of CBD stone and Cholangiocarcinoma/ CA Gallbladder,Correlation of biliary tract cancer and smoking/alcohol drinking At intervention History of smoking and Alcohol drinking in patients diagnosed with Cholangiocarcinoma/ CA Gallbladder